| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 12.337 | 10.163 | 6.622 | 114 | 28.147 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 20.716 | 13.474 | 13.193 | 114 | 18.016 | 0 | - |
| Total Expenses - EUR | 0 | 0 | 0 | 8.360 | 5.055 | 10.670 | 5.644 | 10.646 | 0 | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 12.355 | 8.419 | 2.523 | -5.531 | 7.370 | 0 | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 11.967 | 8.103 | 2.324 | -5.534 | 6.660 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Bioterm Podivas Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 89 | 88 | 0 | 85 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 0 | 0 | 0 | 16.297 | 23.546 | 23.238 | 21.277 | 24.099 | 24.025 | - |
| Inventories | 0 | 0 | 0 | 8.107 | 7.950 | 10.329 | 10.100 | 0 | 0 | - |
| Receivables | 0 | 0 | 0 | 12.337 | 7.595 | 0 | 0 | 16 | 16 | - |
| Cash | 0 | 0 | 0 | -4.148 | 8.001 | 12.909 | 11.177 | 24.083 | 24.010 | - |
| Shareholders Funds | -98 | -97 | 0 | 13.269 | 21.115 | 23.039 | 16.994 | 23.706 | 23.634 | - |
| Social Capital | 45 | 45 | 0 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 187 | 185 | 0 | 3.113 | 2.431 | 199 | 4.283 | 392 | 391 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1629 - 1629" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Bioterm Podivas Srl